ArticleJournal of hematology & oncology2018

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.

Claudio Festuccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.